Earningsreport

Q3/2025 12/31/2024 EPS 16.940 ZacksConsensus 0.200 ActVsEst 16.740 - Beat

Dr. Reddy's Laboratories Ltd  (RDY) 
US:NYSE Investor Relations: drreddys.com/investors